NCT06751823Completed
Evaluation of Zinc in Patients With Type 2 Diabetes
"Serum Zinc Levels and Intake in Type 2 Diabetes: Impact on Pathogenesis and Glycemic Control"
Source: ClinicalTrials.gov · Last updated 30 Dec 2024
Brief summary (registry, in English)
investigation of the impact of zinc level on the development of DM and to elaborate on whether daily consumption of zinc affects the disease's evolution.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 195 (actual)
- First submitted
- 17 Dec 2024
- Start date
- 1 Jan 2024
- Primary completion date
- 17 Dec 2024
- Lead sponsor
- Heliopolis University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06751823
What you commit to
- Study type: Observational
- Participants enrolled: 195
- From 1 Jan 2024 to the primary completion date, 17 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- pregnancy and lactation type 1DM known DM complication other endocrinological disorders malignancy
Who the study is looking for
- confirmed Type 2 DM with no known complication
- more than or equal 40 years old
Age in the registry: 40 years to 100 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cairo University Hospitsl Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.